Management of Hyperglycemia in COVID-19 and Post-COVID-19 Syndrome - Proposed Guidelines for India.
J Assoc Physicians India
; 69(9): 11-12, 2021 Sep.
Article
in En
| MEDLINE
| ID: mdl-34585892
ABSTRACT
SARS-CoV-2 virus spread rapidly all over the globe in 2020 and the second wave has taken our nation, India by storm. The pandemic has posed unique challenges in people with metabolic disorders, including diabetes, hypertension, obesity, pulmonary, cardiovascular, kidney and non-alcoholic fatty liver disease. Uncontrolled diabetes, in conjunction with endocrine, inflammatory and metabolic effects of the infection itself has made management of hyperglycemia in COVID-19 infection particularly challenging. Furthermore, the post-COVID-19 syndrome has also emerged as a sequela in COVID-19 survivors, increasing the risk of death, complications and adding further burden on the health care system. With more than a year of experience, we have gained substantial insight; and now provide practical recommendations on the management of hyperglycemia in COVID-19 as well as post COVID-19 syndrome.
Search on Google
Collection:
01-internacional
Database:
MEDLINE
Main subject:
COVID-19
/
Hyperglycemia
Type of study:
Etiology_studies
/
Guideline
Limits:
Humans
Country/Region as subject:
Asia
Language:
En
Journal:
J Assoc Physicians India
Year:
2021
Type:
Article